眼内レンズ(IOL):医療機器パイプライン分析2020

GlobalDataが発行した調査報告書(GD21MC043)
◆英語タイトル:Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2020
◆商品コード:GD21MC043
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年12月1日
◆ページ数:151
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Intraocular Lens (IOL) – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Intraocular Lens (IOL) – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Intraocular Lens (IOL) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Intraocular lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery. Foldable (phakic) IOL and Polymethyl Methacrylate (PMMA) IOL are tracked under this category.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Intraocular Lens (IOL) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Intraocular Lens (IOL) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Intraocular Lens (IOL) Overview
3 Products under Development
3.1 Intraocular Lens (IOL) – Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) – Pipeline Products by Segment
3.3 Intraocular Lens (IOL) – Pipeline Products by Territory
3.4 Intraocular Lens (IOL) – Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) – Ongoing Clinical Trials
4 Intraocular Lens (IOL) – Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) – Pipeline Products by Stage of Development
5 Intraocular Lens (IOL) Companies and Product Overview
5.1 Abbott Medical Optics Inc Company Overview
5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AcuFocus Inc Company Overview
5.2.1 AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Adaptilens LLC Company Overview
5.3.1 Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Adoptics AG (Inactive) Company Overview
5.4.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 AkkoLens International BV Company Overview
5.5.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Alcon Inc Company Overview
5.6.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Anew Optics, Inc. Company Overview
5.7.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Atia Vision Inc Company Overview
5.8.1 Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bausch & Lomb Inc Company Overview
5.9.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Care Group Company Overview
5.10.1 Care Group Pipeline Products & Ongoing Clinical Trials Overview
5.11 Clarvista Medical Inc Company Overview
5.11.1 Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 ClearSight LLC Company Overview
5.12.1 ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Elenza, Inc. Company Overview
5.13.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Emmetrope Incorporated Company Overview
5.14.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview
5.15 EyeKon Medical Inc Company Overview
5.15.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Hoya Surgical Optics Inc Company Overview
5.16.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 InnFocus Inc Company Overview
5.17.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Innovia LLC Company Overview
5.18.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 Johnson & Johnson Vision Care Inc Company Overview
5.19.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 LayerBio Inc Company Overview
5.20.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 LensGen, Inc. Company Overview
5.21.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 Lenstec Inc Company Overview
5.22.1 Lenstec Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 London Eye Hospital Company Overview
5.23.1 London Eye Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medicontur Medical Engineering Ltd Company Overview
5.24.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Meir Medical Center Company Overview
5.25.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.26 Morcher Gmbh Company Overview
5.26.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview
5.27 Nayam Innovations Pvt Ltd Company Overview
5.27.1 Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Nidek Co Ltd Company Overview
5.28.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Northwestern University Company Overview
5.29.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.30 NuLens Ltd. (Inactive) Company Overview
5.30.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.31 Ocumetics Technology Corp Company Overview
5.31.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview
5.32 Omega Ophthalmics LLC Company Overview
5.32.1 Omega Ophthalmics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.33 PhysIOL SA Company Overview
5.33.1 PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview
5.34 Presbeasy Company Overview
5.34.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview
5.35 Rayner Intraocular Lenses Ltd Company Overview
5.35.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 Sav-Iol SA Company Overview
5.36.1 Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview
5.37 STAAR Surgical Company Company Overview
5.37.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview
5.38 Strathspey Crown LLC Company Overview
5.38.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of East Anglia Company Overview
5.39.1 University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Rochester Company Overview
5.40.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Tampere Company Overview
5.41.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview
5.42 Visidome Ltd Company Overview
5.42.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.43 Visioneering Technologies Inc Company Overview
5.43.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 VisusNano Labs Company Overview
5.44.1 VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview
5.45 VSY Biotechnology BV Company Overview
5.45.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview
5.46 Washington University in St Louis Company Overview
5.46.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
5.47 Xend Company Overview
5.47.1 Xend Pipeline Products & Ongoing Clinical Trials Overview
5.48 Z Lens LLC Company Overview
5.48.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview
6 Intraocular Lens (IOL)- Recent Developments
6.1 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.2 Sep 07, 2020: Pomerantz law firm announces the filing of a class action against Staar Surgical Company and certain officers – STAA
6.3 Jul 12, 2020: Bausch + Lomb expanding Virginia operation, creating 79 new jobs
6.4 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.5 Apr 13, 2020: STAAR Surgical provides covid-19 business update
6.6 Apr 07, 2020: Alcon provides update on covid-19
6.7 Mar 13, 2020: Bausch Health to reduce debt by approximately $100 million using cash generated from operations
6.8 Mar 12, 2020: Alcon announces European launch of Vivity, the only presbyopia-correcting intraocular lens with X-WAVE technology
6.9 Mar 11, 2020: Alcon partners with Actress Cheryl Ladd to share her cataract journey, renewed vision and PanOptimist story
6.10 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov)
6.11 Feb 26, 2020: STAAR Surgical reports fourth quarter and full year 2019 results
6.12 Feb 26, 2020: NanoString Technologies releases fourth quarter and full year 2019 operating results and provides 2020 financial outlook
6.13 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.14 Feb 04, 2020: STAAR Surgical announces the EVO implantable lens US clinical trial is underway with 1st patient implanted at Price Vision Group in Indianapolis on january 30th
6.15 Feb 04, 2020: Santen and Verily establish joint venture to develop and commercialize unique Ophthalmic Devices
6.16 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.17 Jan 13, 2020: STAAR Surgical gains supplemental lens approval for EVO Visian ICL to target post-cataract market opportunity
6.18 Jan 13, 2020: STAAR Surgical reports preliminary fourth quarter net sales growth of 25%
6.19 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.20 Dec 18, 2019: STAAR CFO to retire in 2020
6.21 Dec 17, 2019: STAAR Surgical announces strategic alliance agreement with California Center for Refractive Surgery (CCRS)
6.22 Dec 16, 2019: Bausch Health Resolves “”Stock Drop”" Litigation initially filed in October 2015
6.23 Dec 12, 2019: Bausch + Lomb expands intraocular lens portfolio
6.24 Dec 12, 2019: STAAR Surgical Company announces FDA IDE clinical study approval
6.25 Dec 03, 2019: Johnson & Johnson Vision introduces TECNIS Toric II 1-Piece IOL as new Monofocal Option for Cataract Patients with Astigmatism; Launching Multi-Center, Post-Market Clinical Trials Across U.S.
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Intraocular Lens - Astigmatism - Product Status
Table 11: Intraocular Lens - Astigmatism - Product Description
Table 12: Intraocular Lens - Presbyopia - Product Status
Table 13: Intraocular Lens - Presbyopia - Product Description
Table 14: AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: IC-8 IOL - Product Status
Table 16: IC-8 IOL - Product Description
Table 17: AcuFocus Inc - Ongoing Clinical Trials Overview
Table 18: IC-8 IOL - A Prospective Study of Small Aperture Intraocular Lens (IOL) Implantation in KAMRA Inlay Patients After Inlay Removal
Table 19: IC-8 IOL - Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Table 20: IC-8 IOL - Interindividual Comparison Trial – Two Intraocular Lenses with Extended Depth of Focus
Table 21: Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Adaptilens - Product Status
Table 23: Adaptilens - Product Description
Table 24: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Shape-Changing Accommodating Intraocular Lens - Product Status
Table 26: Shape-Changing Accommodating Intraocular Lens - Product Description
Table 27: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
Table 28: AkkoLens IOL - Product Status
Table 29: AkkoLens IOL - Product Description
Table 30: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status
Table 32: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description
Table 33: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status
Table 34: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description
Table 35: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status
Table 36: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description
Table 37: AcrySof IQ Toric Diopter Range Expansion - Product Status
Table 38: AcrySof IQ Toric Diopter Range Expansion - Product Description
Table 39: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status
Table 40: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description
Table 41: AcrySof IQ Vivity Non-Diffractive IOL - Product Status
Table 42: AcrySof IQ Vivity Non-Diffractive IOL - Product Description
Table 43: FluidVision Lens - Product Status
Table 44: FluidVision Lens - Product Description
Table 45: Intrepid IOL - Product Status
Table 46: Intrepid IOL - Product Description
Table 47: Alcon Inc - Ongoing Clinical Trials Overview
Table 48: AcrySof IQ Vivity Non-Diffractive IOL - Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of the AcrySof Vivity Intraocular Lens with a Target of Slight Myopia in the Non-dominant Eye
Table 49: AcrySof IQ Vivity Non-Diffractive IOL - Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses
Table 50: AcrySof IQ Vivity Non-Diffractive IOL - Vivity Insight: A Study of Patient Satisfaction and Visual Performance

List of Figures
Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 眼内レンズ(IOL):医療機器パイプライン分析2020(Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆